FEBS Letters
Volume 583, Issue 7 , Pages 1141-1146, 2 April 2009

Identification and characterization of Runx2 phosphorylation sites involved in matrix metalloproteinase-13 promoter activation

  • Nagarajan Selvamurugan

      Affiliations

    • Department of Endocrinology, Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai 600 113, India
  • ,
  • Emi Shimizu

      Affiliations

    • Department of Physiology and Biophysics, UMDNJ – Robert Wood Johnson Medical School, 683 Hoes Lane, Piscataway, NJ 08854, USA
  • ,
  • Minnkyong Lee

      Affiliations

    • Department of Physiology and Biophysics, UMDNJ – Robert Wood Johnson Medical School, 683 Hoes Lane, Piscataway, NJ 08854, USA
  • ,
  • Tong Liu

      Affiliations

    • Center for Advanced Proteomics Research, UMDNJ – New Jersey Medical School Cancer Center, Newark, NJ 07103, USA
  • ,
  • Hong Li

      Affiliations

    • Center for Advanced Proteomics Research, UMDNJ – New Jersey Medical School Cancer Center, Newark, NJ 07103, USA
  • ,
  • Nicola C. Partridge

      Affiliations

    • Department of Physiology and Biophysics, UMDNJ – Robert Wood Johnson Medical School, 683 Hoes Lane, Piscataway, NJ 08854, USA
    • Corresponding Author InformationCorresponding author. Fax: +1 732 235 5038.

Received 25 September 2008; received in revised form 24 January 2009; accepted 24 February 2009. published online 02 March 2009.

Edited by Ivan Sadowski

Abstract 

Matrix metalloproteinase-13 (MMP-13) plays a critical role in parathyroid hormone (PTH)-induced bone resorption. PTH acts via protein kinase A (PKA) to phosphorylate and stimulate the transactivation of Runx2 for MMP-13 promoter activation. We show here that PTH stimulated Runx2 phosphorylation in rat osteoblastic cells. Runx2 was phosphorylated on serine 28 and threonine 340 after 8-bromo cyclic adenosine mono phosphate (8-Br-cAMP) treatment. We further demonstrate that in the presence of 8-Br-cAMP, the wild-type Runx2 construct stimulated MMP-13 promoter activity, while the Runx2 construct having mutations at three phosphorylation sites (S28, S347 and T340) was unable to stimulate MMP-13 promoter activity. Thus, we have identified the Runx2 phosphorylation sites necessary for PKA stimulated MMP-13 promoter activation and this event may be critical for bone remodeling.

Abbreviations: PTH, parathyroid hormone, PKA, protein kinase A, 8-Br-cAMP, 8-bromo cyclic adenosine mono phosphate, MMP-13, matrix metalloproteinase-13, MALDI, matrix-assisted laser desorption/ionization, TLC, thin layer chromatography, CAT, chloramphenicol acetyl transferase, GAPDH, glyceraldehyde 3-phosphate dehydrogenase

Keywords: Runx2, Matrix metalloproteinase-13, Collagenase-3, Cyclic adenosine mono phosphate, Parathyroid hormone

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(09)00154-9

doi:10.1016/j.febslet.2009.02.040

FEBS Letters
Volume 583, Issue 7 , Pages 1141-1146, 2 April 2009